Specifically, reduced ALDOB expression in gastric cancer tissues activates downstream glycolytic enzymes by lifting inhibition on the AKT signaling pathway, thereby promoting aerobic glycolysis, tumor growth, and metastasis. This evidence concerns the gene ALDOB and neoplasm.